Long Term Outcome of Patients Receiving Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Haematologic Malignancies

被引：0
|
作者：
Tang, Si Ying [1 ,2 ]
Linn, Yeh Ching [3 ]
Tai, Bee Choo [4 ]
Poon, Michelle L. M. [1 ]
Tan, Lip Kun [1 ]
Tan, Belinda [1 ]
Lim, Yelly [1 ]
Soh, Teck Guan [1 ]
Ramos, Davanaliz Gonzales [1 ]
Hwang, William Y. K. [3 ]
Koh, Liang Piu [1 ,2 ]
机构：
[1] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Dept Med, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore
[4] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P182
引用
收藏
页码：279 / 279
页数：1
相关论文
共 50 条
  • [31] Clofarabine-melphalan-alemtuzumab conditioning for allogeneic haematopoietic cell transplantation in advanced haematologic malignancies. Immunosuppression and long-term responses compared with fludarabinemelphalan-alemtuzumab
    van Besien, K.
    Kline, J.
    Godley, L.
    Larson, R. A.
    Odenike, O.
    Stock, W.
    Horowitz, S.
    Wickrema, A.
    Allen, S.
    del Cerro, P.
    Schroeder, L.
    Artz, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S286 - S287
  • [32] Alloreactivity as therapeutic principle in the treatment of hematologic malignancies - Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning
    Petersen, Soren Lykke
    DANISH MEDICAL BULLETIN, 2007, 54 (02) : 112 - 139
  • [33] Impact of Hyperferritinemia on the Outcome of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies
    Barba, Pere
    Valcarcel, David
    Antonio Perez-Simon, Jose
    Fernandez-Aviles, Francesc
    Luis Pinana, Jose
    Martino, Rodrigo
    Lopez-Anglada, Lucia
    Rovira, Montserrat
    Garcia-Cadenas, Irene
    Novelli, Silvana
    Carreras, Enric
    Lopez Corral, Lucia
    Sierra, Jorge
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (04) : 597 - 601
  • [34] Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia
    Gyurkocza, Boglarka
    Storb, Rainer
    Storer, Barry E.
    Chauncey, Thomas R.
    Lange, Thoralf
    Shizuru, Judith A.
    Langston, Amelia A.
    Pulsipher, Michael A.
    Bredeson, Christopher N.
    Maziarz, Richard T.
    Bruno, Benedetto
    Petersen, Finn B.
    Maris, Michael B.
    Agura, Edward
    Yeager, Andrew
    Bethge, Wolfgang
    Sahebi, Firoozeh
    Appelbaum, Frederick R.
    Maloney, David G.
    Sandmaier, Brenda M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (17) : 2859 - 2867
  • [35] Treosulfan/fludarabine conditioning for allogeneic haematopoietic stem cell transplant in patients with haematologic malignancies
    Baronciani, D
    Rambaldi, A
    Mico, C
    Delpano, S
    Dessalvi, P
    Angelucci, E
    BONE MARROW TRANSPLANTATION, 2006, 37 : S325 - S325
  • [36] HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
    Maris, MB
    Niederwieser, D
    Sandmaier, BM
    Storer, B
    Stuart, M
    Maloney, D
    Petersdorf, E
    McSweeney, P
    Pulsipher, M
    Woolfrey, A
    Chauncey, T
    Agura, E
    Heimfeld, S
    Slattery, J
    Hegenbart, U
    Anasetti, C
    Blume, K
    Storb, R
    BLOOD, 2003, 102 (06) : 2021 - 2030
  • [37] Allogeneic stem cell transplantation in the 7th decade of life for patients with unfavourable haematologic malignancies: impact of transplant characteristics on long-term outcome
    Beelen, D.
    Ditschkowski, M.
    Elmaagacli, A.
    Ottinger, H.
    Trenschel, R.
    Steckel, N.
    Schulte, C.
    Kordelas, L.
    Koldehoff, M.
    Engelhard, M.
    Grosse-Wilde, H.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S48 - S48
  • [38] Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
    Robin, Marie
    de Wreede, Liesbeth C.
    Wolschke, Christine
    Schetelig, Johannes
    Eikema, Dirk-Jan
    Van Lint, Maria Teresa
    Knelange, Nina Simone
    Beelen, Dietrich
    Brecht, Arne
    Niederwieser, Dietger
    Vitek, Antonin
    Bethge, Wolfgang
    Arnold, Renate
    Finke, Juergen
    Volin, Liisa
    Yakoub-Agha, Ibrahim
    Nagler, Arnon
    Poire, Xavier
    Einsele, Hermann
    Chevallier, Patrice
    Holler, Ernst
    Ljungman, Per
    Robinson, Stephen
    Radujkovic, Aleksandar
    McLornan, Donal
    Chalandon, Yves
    Kroeger, Nicolaus
    HAEMATOLOGICA, 2019, 104 (09) : 1782 - 1788
  • [39] Allogeneic haematopoietic cell transplantation with nonmyeloablative conditioning in Denmark
    Masmas, Tania Nicole
    Kornblit, Brian
    Sengelov, Henrik
    Madsen, Hans O.
    Jakobsen, Bodil K.
    Olesen, Gitte
    Vindelov, Lars L.
    DANISH MEDICAL BULLETIN, 2010, 57 (05)
  • [40] Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies
    Connor, Matthew P.
    Loren, Alison W.
    Hexner, Elizabeth O.
    Martin, Mary Ellen
    Gill, Saar I.
    Luger, Selina M.
    Mangan, James K.
    Perl, Alexander E.
    McCurdy, Shannon R.
    Pratz, Keith W.
    Timlin, Colleen
    Freyer, Craig W.
    Carulli, Alison
    Catania, Christopher
    Smith, Jacqueline
    Hollander, Lauren
    Zebrowski, Alexis M.
    Stadtmauer, Edward A.
    Porter, David L.
    Frey, Noelle, V
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (02): : 113 - 118
12345